Find clinical trials for Colon Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer

Colonic Cancer

Cancer

Lung Cancer

Neoplasm Metastasis

Non-Small-Cell Lung Carcinoma

Adenocarcinoma

Colon Cancer trials near Houston, TX, USA:

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

To learn if cemiplimab can help to control dMMR colon cancer....

Enrolling

Colon Cancer

Drug: Cemiplimab

Phase 2

M.D. Anderson Cancer Center

Houston, Texas, United States

Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer

with enhanced numbers of immune cells in surgically resected colon tumors.Participants will receive 4 cycles of atezolizumab in com...

Not yet enrolling

Stage II Colon Cancer

Stage III Colon Cancer

Drug: Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2

Drug: Oxaliplatin injection 85mg/m2 + Leucovorin 400mg/m2 + 5-Fluorouracil 2400mg/m2

Phase 2

Baylor College of Medicine

Houston, Texas, United States

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

doses of selected chemotherapies will be safe and tolerable for cancer patients with advanced solid tumors. The highest tolerated d...

Active, not recruiting

Breast Cancer

Colon Neoplasms

Drug: Erlotinib

Drug: Temsirolimus

Phase 1

AstraZeneca

Houston, Texas, United States and 3 other locations

A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread (CheckMate142)

The purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in mea ...

Active, not recruiting

Microsatellite Unstable Colorectal Cancer

Microsatellite Stable Colorectal Cancer

Drug: Ipilimumab

Drug: BMS-986016

Phase 2

Bristol-Myers Squibb (BMS)

Houston, Texas, United States and 31 other locations

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

with histologically or cytologically confirmed stage IV colorectal cancer coming form three different patient populations:* Cohort 1a: 6 pat...

Active, not recruiting

Stage IV Rectal Cancer

Metastatic Colorectal Cancer

Drug: ATP128

Drug: BI 754091

Phase 1

Amal Therapeutics

Houston, Texas, United States and 11 other locations

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

patients with RAS-Mutated, microsatellite stable (MSS) colorectal cancer that has spread to other places in the body (metastatic) or cannot ...

Enrolling

Stage IVA Colon Cancer AJCC v8

Stage IV Colon Cancer AJCC v8

Biological: Nivolumab

Drug: CXCR1/2 Inhibitor SX-682

Phase 1, Phase 2

M.D. Anderson Cancer Center

Houston, Texas, United States

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer (SEAMARK)

and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...

Enrolling

Metastatic Colorectal Cancer

Biological: Pembrolizumab

Biological: Cetuximab

Phase 2

Pfizer

Houston, Texas, United States and 111 other locations

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting

Any Solid Tumor

Glioma

Drug: LY3410738

Drug: Gemcitabine

Phase 1

Lilly

Houston, Texas, United States and 32 other locations

da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...

Active, not recruiting

Benign or Malignant Rectal or Colon Tumors

Colorectal Cancer

Device: Robotic Assisted Surgery

Intuitive Surgical

Houston, Texas, United States and 8 other locations

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer (CRC)

Drug: RMC-6236

Drug: RMC-9805

Phase 1

Revolution Medicines

Houston, Texas, United States and 16 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Colon Cancer in .css-epvm6{white-space:nowrap;}Houston, TX

Related conditions:

Colon Cancer trials near Houston, TX, USA:

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread (CheckMate142)

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer (SEAMARK)

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Find clinical trials for Colon Cancer in Houston, TX